Sylvie Freeman

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party”.

2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party

Blood(2021)10.1182/blood.2021013626

N/A

0.992DataRank · unranked

745 citations

Sylvie Freeman, Gert J. Ossenkoppele, Francesco Buccisano, Christopher S. Hourigan, Lok Lam Ngai +40 more

Association of Measurable Residual Disease With Survival Outcomes in Patients With Acute Myeloid Leukemia

JAMA Oncology(2020)10.1001/jamaoncol.2020.4600

N/A

0.891DataRank · unranked

378 citations

Shouhao Zhou, Chenqi Fu, Donald A. Berry, Roland B. Walter, Sylvie Freeman +8 more

Pre-emptive detection and evolution of relapse in acute myeloid leukemia by flow cytometric measurable residual disease surveillance

Leukemia(2024)10.1038/s41375-024-02300-z

N/A

0.425DataRank · unranked

16 citations

Gege Gui, Florent Dumézy, Christophe Roumier, Georgia Andrew, Sarah Green +8 more

Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts

Leukemia(2024)10.1038/s41375-024-02143-8

N/A

0.292DataRank · unranked

6 citations

Andrew H. Wei, Sumithra J. Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse‐Chieh Teh +24 more

Moving toward a conceptualization of measurable residual disease in myelodysplastic syndromes

Blood Advances(2023)10.1182/bloodadvances.2023010098

N/A

0DataRank · unranked

16 citations

Peter D. Aplan, Sylvie Freeman, Steven Z. Pavletic, Eduard Schulz

Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower‐intensity therapy: Roadmap from an ELN‐DAVID expert panel

American Journal of Hematology(2023)10.1002/ajh.27087

N/A

0DataRank · unranked

24 citations

Jacqueline Cloos, Francesco Buccisano, Richard Dillon, Konstanze Döhner, Sylvie Freeman +12 more

Optimal prognostic threshold for measurable residual disease positivity by multiparameter flow cytometry in acute myeloid leukemia (AML)

Leukemia(2024)10.1038/s41375-024-02378-5

N/A

0DataRank · unranked

12 citations

Megan Othus, Sylvie Freeman, Francesco Buccisano, Lok Lam Ngai, Ian Thomas +11 more

Pre-emptive Detection and Evolution of Relapse in Acute Myeloid Leukemia by Flow Cytometric Measurable Residual Disease Surveillance

Research Square(2024)10.21203/rs.3.rs-3978470/v1

N/A

0DataRank · unranked

0 citations

Nicholas McCarthy, Gege Gui, Florent Dumézy, Christophe Roumier, Georgia Andrew +8 more